Bioinformatic-driven search for metabolic biomarkers in disease

Journal of Clinical Bioinformatics

Volumn 1, Issue 1, 2011, Pages

  Baumgartner, Christian ^a   Osl, Melanie ^a   Netzer, Michael ^a   Baumgartner, Daniela ^b  

^a UNIVERSITY FOR HEALTH SCIENCES   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80155143971     PISSN: None     EISSN: 20439113     Source Type: Journal    
DOI: 10.1186/2043-9113-1-2     Document Type: Review

References (80)

1. Biomarkers Definitions Working Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001, 69:89-95. 10.1067/mcp.2001.113989, 11240971, Biomarkers Definitions Working Group.
2. Gerszten RE, Wang TJ. The search for new cardiovascular biomarkers. Nature 2008, 451:949-952. 10.1038/nature06802, 18288185.
3. Lintula S, Hotakainen K. Developing biomarkers for improved diagnosis and treatment outcome monitoring of bladder cancer. Expert Opin Biol Ther 2010, 10:1169-1180. 10.1517/14712598.2010.489546, 20446896.
4. Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engström G, Persson M, Smith JG, Magnusson M, Christensson A, Struck J, Morgenthaler NG, Bergmann A, Pencina MJ, Wang TJ. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009, 302:49-57. 10.1001/jama.2009.943, 19567439.
5. Ackermann BL, Hale JE, Duffin KL. The role of mass spectrometry in biomarker discovery and measurement. Curr Drug Metab 2006, 7:525-539. 10.2174/138920006777697918, 16787160.
6. Hood BL, Stewart NA, Conrads TP. Development of high-throughput mass spectrometry-based approaches for cancer biomarker discovery and implementation. Clin Lab Med 2009, 29:115-138. 10.1016/j.cll.2009.01.007, 19389555.
7. Kulasingam V, Pavlou MP, Diamandis EP. Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer. Nat Rev Cancer 2010, 10:371-378. 10.1038/nrc2831, 20383179.
8. Rifai N, Gerszten RE. Biomarker discovery and validation. Clin Chem 2006, 52:1635-1637. 10.1373/clinchem.2006.074492, 16940460.
9. Dettmer K, Aronov PA, Hammock BD. Mass spectrometry-based metabolomics. Mass Spectrom Rev 2007, 26:51-78. 10.1002/mas.20108, 1904337, 16921475.
10. Lenz EM, Wilson ID. Analytical strategies in metabonomics. J Proteome Res 2007, 6:443-458. 10.1021/pr0605217, 17269702.
11. Millonig G, Praun S, Netzer M, Baumgartner C, Dornauer A, Mueller S, Villinger J, Vogel W. Non-invasive diagnosis of liver diseases by breath analysis using an optimized ion-molecule reaction-mass spectrometry approach: a pilot study. Biomarkers 2010, 15:297-306. 10.3109/13547501003624512, 20151876.
12. Bajtarevic A, Ager C, Pienz M, Klieber M, Schwarz K, Ligor M, Ligor T, Filipiak W, Denz H, Fiegl M, Hilbe W, Weiss W, Lukas P, Jamnig H, Hackl M, Haidenberger A, Buszewski B, Miekisch W, Schubert J, Amann A. Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer 2009, 9:348. 10.1186/1471-2407-9-348, 2761408, 19788722.
13. Baumgartner C, Lewis GD, Netzer M, Pfeifer B, Gerszten RE. A new data mining approach for profiling and categorizing kinetic patterns of metabolic biomarkers after myocardial injury. Bioinformatics 2010, 26:1745-1751. 10.1093/bioinformatics/btq254, 20483816.
14. Pfeifer B, Aschaber J, Baumgartner C, Dreiseitl RSM, Schreier G, Tilg B. A data warehouse for prostate cancer biomarker discovery. Proceedings of the 8th International Conference on Bioinformatics & Computational Biology, BIOCOMP 2007 2007, 323-327. Las Vegas, NV: CSREA Press.
15. Lee TJ, Pouliot Y, Wagner V, Gupta P, Stringer-Calvert DWJ, Tenenbaum JD, Karp PD. BioWarehouse: a bioinformatics database warehouse toolkit. BMC Bioinformatics 2006, 7:170. 10.1186/1471-2105-7-170, 1444936, 16556315.
16. Knorr EM, Ng RT, Tucakov V. Distance-based outliers: algorithms and applications. VLDB Journal 2000, 8:237-253.
17. Breunig MM, Kriegel H, Ng RT, Sander J. LOF: Identifying density-based local outliers. Proceedings of the ACM SIGMOD International Conference on Management of Data 2000, 93-104.
18. Papadimitriou S, Kitagawa H, Gibbons PB, Faloutsos C. LOCI: Fast outlier detection using the local correlation integral. Proceedings of the 19th International Conference on Data Engineering 2003, 315-326.
19. Larrañaga P, Calvo B, Santana R, Bielza C, Galdiano J, Inza I, Lozano JA, Armañanzas R, Santafé G, Pérez A, Robles V. Machine learning in bioinformatics. Brief Bioinform 2006, 7:86-112.
20. Bhaskar H, Hoyle DC, Singh S. Machine learning in bioinformatics: a brief survey and recommendations for practitioners. Comput Biol Med 2006, 36:1104-1125. 10.1016/j.compbiomed.2005.09.002, 16226240.
21. Shulaev V. Metabolomics technology and bioinformatics. Brief Bioinform 2006, 7:128-139. 10.1093/bib/bbl012, 16772266.
22. Tarca AL, Carey VJ, Chen XW, Romero R, Drǎghici S. Machine learning and its applications to biology. PLoS Comput Biol 2007, 3:e116. 10.1371/journal.pcbi.0030116, 1904382, 17604446.
23. Barla A, Jurman G, Riccadonna S, Merler S, Chierici M, Furlanello C. Machine learning methods for predictive proteomics. Brief Bioinform 2008, 9:119-128. 10.1093/bib/bbn008, 18310105.
24. Baumgartner C, Graber A. Data mining and knowledge discovery in metabolomics. Successes and new directions in data mining 2008, 141-166. New York: Information Science Reference, Masseglia F, Poncelet P, Teisseire M Hershey.
25. Lee JK, Williams PD, Cheon S. Data mining in genomics. Clin Lab Med 2008, 28:145-166. viii, 10.1016/j.cll.2007.10.010, 2253491, 18194724.
26. Inza I, Calvo B, Armañanzas R, Bengoetxea E, Larrañaga P, Lozano JA. Machine learning: an indispensable tool in bioinformatics. Methods Mol Biol 2010, 593:25-48. full_text, 19957143.
27. Datta S, Pihur V. Feature selection and machine learning with mass spectrometry data. Methods Mol Biol 2010, 593:205-229. full_text, 19957152.
28. Hall MA, Holmes G. Benchmarking attribute selection techniques for discrete class data mining. IEEE T Knowl Data En 2003, 15:1437-1447.
29. Saeys Y, Inza I, Larrañaga P. A review of feature selection techniques in bioinformatics. Bioinformatics 2007, 23:2507-2517. 10.1093/bioinformatics/btm344, 17720704.
30. Saeys Y, Abeel T, Van de Peer Y. Robust feature selection using ensemble feature selection techniques. Proceedings of the European Conference on Machine Learning and Knowledge Discovery in Databases. Part II 2008, 313-325. Berlin, Heidelberg: Springer-Verlag, Vol. 5212 of Lecture Notes in Artificial Intelligence.
31. Netzer M, Millonig G, Osl M, Pfeifer B, Praun S, Villinger J, Vogel W, Baumgartner C. A new ensemble-based algorithm for identifying breath gas marker candidates in liver disease using ion molecule reaction mass spectrometry. Bioinformatics 2009, 25:941-947. 10.1093/bioinformatics/btp093, 19223453.
32. Lehmann EL, Romano JP. Testing statistical hypotheses 2005, New York, NY: Springer Verlag, 3.
33. Jolliffe IT. Principal component analysis 2002, New York, NY: Springer Verlag.
34. Ringnér M. What is principal component analysis?. Nat Biotechnol 2008, 26:303-304.
35. Robnik-Sikonja M, Kononenko I. Theoretical and empirical analysis of relieff and rrelief. Mach Learning 2003, 53:23-69.
36. Osl M, Dreiseitl S, Pfeifer B, Weinberger K, Klocker H, Bartsch G, Schäfer G, Tilg B, Graber A, Baumgartner C. A new rule-based data mining algorithm for identifying metabolic markers in prostate cancer using tandem mass spectrometry. Bioinformatics 2008, 24:2908-2914. 10.1093/bioinformatics/btn506, 18815183.
37. Shin H, Sheu B, Joseph M, Markey MK. Guilt-by-association feature selection: identifying biomarkers from proteomic profiles. J Biomed Inform 2008, 41:124-136. 10.1016/j.jbi.2007.04.003, 17544868.
38. Guyon I, Weston J, Barnhill S, Vapnik V. Gene Selection for Cancer Classification using Support Vector Machines. Mach Learn 2002, 46:389-422.
39. Enot DP, Beckmann M, Overy D, Draper J. Predicting interpretability of metabolome models based on behavior, putative identity, and biological relevance of explanatory signals. Proc Natl Acad Sci USA 2006, 103:14865-14870. 10.1073/pnas.0605152103, 1595442, 16990432.
40. Crowder MJ, Hand DJ. Analysis of repeated measures 1990, Boca Raton, FL: Chapman &Hall/CRC Press.
41. Baumgartner C, Böhm C, Baumgartner D. Modelling of classification rules on metabolic patterns including machine learning and expert knowledge. J Biomed Inform 2005, 38:89-98. 10.1016/j.jbi.2004.08.009, 15796999.
42. Ho S, Lukacs Z, Hoffmann GF, Lindner M, Wetter T. Feature construction can improve diagnostic criteria for high-dimensional metabolic data in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency. Clin Chem 2007, 53:1330-1337. 10.1373/clinchem.2006.081802, 17513288.
43. Chace DH, Sherwin JE, Hillman SL, Lorey F, Cunningham GC. Use of phenylalanine-totyrosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24 hours. Clin Chem 1998, 44:2405-2409.
44. Ding C, Peng HC. Minimum Redundancy Feature Selection from Microarray Gene Expression Data. Proceedings of the Second IEEE Computational Systems Bioinformatics Conference 2003, 523-528. Stanford, CA.
45. Osl M, Dreiseitl S, Netzer M, Cerqueira F, Pfeifer B, Baumgartner C. Demoting redundant features to improve the discriminatory ability in cancer data. J Biomed Inform 2009, 42:721-725. 10.1016/j.jbi.2009.05.006, 19460463.
46. Hosmer DW, Lemeshow S. Applied logistic regression 2000, New York, NY: Wiley, 2.
47. Quinlan JR. C4.5: Programs for Machine Learning 1993, San Francisco, CA: Morgan Kaufmann.
48. Mitchell TM. Machine learning 1997, Boston, MA: McGraw-Hill.
49. Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian data analysis 2004, Boca Raton, FL: Chapman & Hall/CRC Press, 2.
50. Shawe-Taylor J, Cristianini N. Kernel methods for pattern analysis 2004, Cambridge, UK: Cambridge University Press.
51. Yang ZR. Biological applications of support vector machines. Brief Bioinform 2004, 5:328-338. 10.1093/bib/5.4.328, 15606969.
52. Raudys S. Statistical and neural classifiers 2001, London: Springer-Verlag.
53. Harper PR. A review and comparison of classification algorithms for medical decision making. Health Policy 2005, 71:315-331. 10.1016/j.healthpol.2004.05.002, 15694499.
54. Bagos PG, Nikolopoulos GK. A method for meta-analysis of case-control genetic association studies using logistic regression. Stat Appl Genet Mol Biol 2007, 6:Article17.
55. Ramasamy A, Mondry A, Holmes CC, Altman DG. Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS Med 2008, 5:e184. 10.1371/journal.pmed.0050184, 2528050, 18767902.
56. Lewis GD, Wei R, Liu E, Yang E, Shi X, Martinovic M, Farrell L, Asnani A, Cyrille M, Ramanathan A, Shaham O, Berriz G, Lowry PA, Palacios I, Tasan M, Roth FP, Min J, Baumgartner C, Keshishian H, Addona T, Mootha VK, Rosenzweig A, Carr SA, Fifer MA, Sabatine MS, Gerszten RE. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest 2008, 118:3503-3512. 10.1172/JCI35111, 2525696, 18769631.
57. Lakkis NM, Nagueh SF, Kleiman NS, Killip D, He ZX, Verani MS, Roberts R, Spencer WH. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 1998, 98:1750-1755.
58. Witten IH, Frank E. Data Mining - Practical Machine Learning Tools and Techniques with JAVA Implementations 2000, San Francisco, CA: Morgan Kaufmann Publishers.
59. Kohavi R. A study of cross-validation and bootstrap for accuracy estimation and model selection. Proceedings of the 17th International Joint Conference on Artificial Intelligence 1995, 2:1137-1143.
60. Xiao Y, Hua J, Dougherty ER. Quantification of the impact of feature selection on the variance of cross-validation error estimation. EURASIP J Bioinform Syst Biol 2007, 16354. 1893013, 17713587.
61. Baumgartner C, Böhm C, Baumgartner D, Marini G, Weinberger K, Olgemöller B, Liebl B, Roscher AA. Supervised machine learning techniques for the classification of metabolic disorders in newborns. Bioinformatics 2004, 20:2985-2996. 10.1093/bioinformatics/bth343, 15180934.
62. Cerami EG, Bader GD, Gross BE, Sander C. cPath: open source software for collecting, storing, and querying biological pathways. BMC Bioinformatics 2006, 7:497. 10.1186/1471-2105-7-497, 1660554, 17101041.
63. Rahman SA, Advani P, Schunk R, Schrader R, Schomburg D. Metabolic pathway analysis web service (Pathway Hunter Tool at CUBIC). Bioinformatics 2005, 21:1189-1193. 10.1093/bioinformatics/bti116, 15572476.
64. Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 1999, 27:29-34. 10.1093/nar/27.1.29, 148090, 9847135.
65. Okuda S, Yamada T, Hamajima M, Itoh M, Katayama T, Bork P, Goto S, Kanehisa M. KEGG Atlas mapping for global analysis of metabolic pathways. Nucleic Acids Res 2008, 36(Web Server issue):W423-426. 10.1093/nar/gkn282, 2447737, 18477636.
66. Jorda A, Cabo J, Grisolia S. Changes in the levels of urea cycle enzymes and in metabolites thereof in diabetes. Enzyme 1981, 26:240-244.
67. Wu G, Meininger CJ. Impaired arginine metabolism and NO synthesis in coronary endothelial cells of the spontaneously diabetic BB rat. Am J Physiol 1995, 269:H1312-1318.
68. Ng A, Bursteinas B, Gao Q, Mollison E, Zvelebil M. Resources for integrative systems biology: from data through databases to networks and dynamic system models. Brief Bioinform 2006, 7:318-330. 10.1093/bib/bbl036, 17040977.
69. Schuster S, von Kamp A, Pachkov M. Understanding the roadmap of metabolism by pathway analysis. Methods Mol Biol 2007, 358:199-226. full_text, 17035688.
70. Ekins S, Nikolsky Y, Bugrim A, Kirillov E, Nikolskaya T. Pathway mapping tools for analysis of high content data. Methods Mol Biol 2007, 356:319-350.
71. Kussmann M, Raymond F, Affolter M. OMICS-driven biomarker discovery in nutrition and health. J Biotechnol 2006, 124:758-787. 10.1016/j.jbiotec.2006.02.014, 16600411.
72. Street JM, Dear JW. The application of mass-spectrometry-based protein biomarker discovery to theragnostics. Br J Clin Pharmacol 2010, 69:367-378. 10.1111/j.1365-2125.2009.03610.x, 20406221.
73. Kohn EC, Azad N, Annunziata C, Dhamoon AS, Whiteley G. Proteomics as a tool for biomarker discovery. Dis Markers 2007, 23:411-417.
74. Baumgartner C, Rejtar T, Kullolli M, Akella LM, Karger BL. SeMoP: A New Computational Strategy for the Unrestricted Search for Modified Peptides Using LC-MS/MS Data. J Proteome Res 2008, 7:4199-4208. 10.1021/pr800277y, 2556171, 18686985.
75. Beger RD. Cambridge Healthtech Institute's 7th Annual, identifying and validating metabolic markers for drug development and clinical studies. Expert Rev Mol Diagn 2007, 7:113-115. 10.1586/14737159.7.2.113, 17331060.
76. Hong H, Goodsaid F, Shi L, Tong W. Molecular biomarkers: a US FDA effort. Biomark Med 2010, 4:215-225. 10.2217/bmm.09.81, 20406066.
77. Ganesalingam J, Bowser R. The application of biomarkers in clinical trials for motor neuron disease. Biomark Med 2010, 4:281-297. 10.2217/bmm.09.71, 20406070.
78. Rosenson RS. New technologies personalize diagnostics and therapeutics. Curr Atheroscler Rep 2010, 12:184-186. 10.1007/s11883-010-0103-x, 20425257.
79. Jain KK. Personalised medicine for cancer: from drug development into clinical practice. Expert Opin Pharmaco 2005, 6:1463-1476.
80. Netto GJ, Epstein JI. Theranostic and prognostic biomarkers: genomic applications in urological malignancies. Pathology 2010, 42:384-94. 10.3109/00313021003779145, 20438413.